Nateglinide (Avera McKennan Hospital)
Welcome to the PulseAid listing for the Nateglinide drug offered from Avera McKennan Hospital. This Glinide [EPC],Potassium Channel Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
| NON-PROPRIETARY NAME: | Nateglinide |
| SUBSTANCE NAME: | NATEGLINIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Glinide [EPC],Potassium Channel Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-02-22 |
| END MARKETING DATE: | 0000-00-00 |
Nateglinide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nateglinide from Avera McKennan Hospital |
| LABELER NAME: | Avera McKennan Hospital |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 60(mg/1) |
| START MARKETING DATE: | 2016-02-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69189-0984_514fc039-2e1a-428d-92d1-7e793f864c94 |
| PRODUCT NDC: | 69189-0984 |
| APPLICATION NUMBER: | ANDA077463 |
Other NATEGLINIDE Pharmaceutical Manufacturers / Labelers:
